Krystal Biotech received FDA RMAT designation for inhaled KB707 in advanced NSCLC, based on a 36% ORR in heavily pretreated ...
Breakthrough Study Confirms HYD’s 30-Year Research on Deuterium Modulation in Cancer Gene Expression
The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division.
Across neuroscience, biomedical engineering and artificial intelligence, researchers from Carnegie Mellon University are exploring how pain is measured, understood and treated to support safer, more ...
After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by ...
Among them was David Liu, a biochemist at the Broad Institute and Harvard University in Cambridge, Massachusetts. Liu isn’t a ...
Despite its strong influence, APOE is not the sole cause of Alzheimer’s or other dementias. Even among people with the highest genetic risk, those who carry two ε4 variants, lifetime risk of Alzheimer ...
After a series of deaths in patients taking Sarepta Therapeutics’ gene therapies, doubt has crept into investor sentiments ...
Parent Psychotherapy doesn’t just heal emotional wounds — it repairs a biological process that could benefit kids for life.
Q1 2026 Management View CEO Robert Mauch announced the completion of the acquisition of the majority of the remaining equity interest in OneOncology, emphasizing, "we are raising our fiscal 2026 ...
Over the next two years, the planned funding will be allocated to projects that have received some FDA feedback as well as emerging efforts.
Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons that can correct multiple disease-causing mutations at once. Unlike ...
Phacilitate’s annual event dawns as cell and gene therapies reach a new tipping point: the science has hit new heights just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results